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INTRODUCTION
Toxoplasma gondii is an apicomplexan parasite with a broad 
host range of most warm-blooded animals from mammals to 
birds [1]. The protozoan parasite can cause congenital defects 
or abortion and neonatal complications in immune compro-
mised patients [2]. Cats are the final host of this pathogen be-
cause they are the unique species that excretes infectious oo-
cysts [3,4]. Oocysts can be introduced into humans while gar-
dening or consuming fresh products or drinking water con-
taminated with the oocysts. Because T. gondii persists in pigs, 
goats, and other mammals as the tissue-cyst forms after infec-
tion by the oocyst, humans can be infected by consuming in-
sufficiently cooked meats carrying the tissue cysts also. Another 
route of infection is from infected mother to her fetus via pla-
cental transmission of T. gondii, a process known as congenital 
toxoplasmosis. The congenital toxoplasmosis may cause still-
birth or abortion in addition to serious damages to the fetus, 
such as severe neurological disorders after delivery [5]. For these 
reasons, control of T. gondii transmission from cats is one of 
the best ways to prevent its infection to humans. Monitoring 
of T. gondii-specific antibodies in cats is important because the 
detection of oocysts or direct antigens is virtually impossible 
in the field conditions.
Several serological methods have been developed for detec-
tion of T. gondii infection [6-8]. ELISA and latex agglutination 
test (LAT) are popularly and commercially available for the se-
rodiagnosis of feline toxoplasmosis and western blot analysis 
is normally used for confirmation. However, the procedures of 
these methods are laborious and time-consuming and require 
expertise and equipments, rendering them from point-of-care 
testing. To overcome these disadvantages, detection method in 
the form of rapid diagnostic test (RDT) have been introduced. 
Recently, a truncated SAG2-loaded RDT was developed and 
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Abstract: Rapid serodiagnostic methods for Toxoplasma gondii infection in cats are urgently needed for effective control 
of transmission routes toward human infections. In this work, 4 recombinant T. gondii antigens (SAG1, SAG2, GRA3, and 
GRA6) were produced and tested for the development of rapid diagnostic test (RDT). The proteins were expressed in Esch-
erichia coli, affinity-purified, and applied onto the nitrocellulose membrane of the test strip. The recombinant SAG1 (rSAG1) 
showed the strongest antigenic activity and highest specificity among them. We also performed clinical evaluation of the 
rSAG1-loaded RDT in 182 cat sera (55 household and 127 stray cats). The kit showed 0.88 of kappa value comparing with 
a commercialized ELISA kit, which indicated a significant correlation between rSAG1-loaded RDT and the ELISA kit. The 
overall sensitivity and specificity of the RDT were 100% (23/23) and 99.4% (158/159), respectively. The rSAG1-loaded 
RDT is rapid, easy to use, and highly accurate. Thus, it would be a suitable diagnostic tool for rapid detection of antibod-
ies in T. gondii-infected cats under field conditions.
Key words: Toxoplasma gondii, cat, rapid diagnostic test, serodiagnosis, recombinant SAG1
•Received 25 April 2010, revised 23 June 2011, accepted 27 June 2011.
*Corresponding author (howoo@catholic.ac.kr)
†Chom-Kyu Chong and Wooseog Jeong equally contributed as the first author.208   Korean J Parasitol Vol. 49, No. 3: 207-212, September 2011
evaluated for its diagnostic properties on infected and unin-
fected cats [9]. Nevertheless, the potential of other antigens of 
T. gondii to be used in diagnosis as an RDT system is largely un-
known. To our knowledge, the crude extract or somatic anti-
gens of T. gondii was generally applied as raw materials of diag-
nostic systems, including ELISA and LAT [10,11]. However, the 
use of these biomaterials can evoke several diagnostic pro  blems, 
such as false positives, cross-reactions, or lot-to-lot variations 
of the kits [12]. To solve these matters, recombinant proteins 
which are specific to T. gondii antibodies have been introduced. 
Several antigens of T. gondii have been studied and reported 
[13-15]. Among them, surface antigens (SAG) and dense gran-
ule proteins (GRA) are mostly used as antigenic materials of 
the diagnostic kit to detect antibodies against T. gondii.
In this study, we investigated the antigenic properties as well 
as the suitability of 4 recombinant proteins, SAG1, SAG2, GRA3, 
and GRA6, to be used in the development of RDT for T. gondii. 
We then developed a recombinant SAG1 (rSAG1)-based RDT 
kit which could specifically detect T. gondii antibodies in cat 
blood. Finally, we evaluated its serodiagnostic performances 
using clinical specimens from household and stray cats in Ko-
rea.
MATERIALS AND METHODS
Clinical samples
A total of 182 cases of feline sera (55 cases of household and 
127 cases of stray cats) were kindly provided by the National 
Veterinary Research and Quarantine Service (NVRQS, Anyang, 
Korea). The sera were collected in Gyeonggi-do and Jeollabuk-
do provinces in Korea from 2009 to 2010. All sera were exam-
ined by RDT kit and the results were compared with those of a 
commercially available ELISA kit (ID Screen® Toxoplasmosis 
Indirect, ID VET Inc., Montpellier, France).
Preparation of recombinant proteins from T. gondii
Recombinant proteins of SAG1, SAG2, GRA3, and GRA6 
were produced in BL21 (DE3) strain of E. coli to test the antige-
nicity against T. gondii antibodies. Briefly, cells containing the 
expression vector for each protein were grown at 37˚C in LB 
medium to an OD600 of 0.7-0.8. Protein expression was indu-
ced with 0.5 mM IPTG for 4 hr at 30˚C. The pellet was resus-
pended in the standard buffer (50 mM Tris-HCl, pH 7.5, con-
taining 10 mM EDTA and 1 mM PMSF) and sonicated on ice. 
The supernatant after centrifugation at 20,000 g for 20 min was 
applied on a GSH-coupled Sepharose 6B column. The bound 
GST-fused recombinant protein was recovered with the elution 
buffer (50 mM Tris-HCl, pH 7.5, 15 mM GSH). The purified 
protein was identified by SDS-PAGE analysis, and protein con-
centration was determined by the method of Bradford [16].
Preparation of colloidal gold and conjugation with 
recombinant proteins 
Colloidal gold particles (40 nm mean diameter) were pre-
pared according to the procedure described [17]. Briefly, 100 
ml of 0.01% HAuCl4 solution was boiled thoroughly. Then, 1.8 
ml of 1% trisodium citrate solution was added under constant 
stirring. After the color change to wine-red for about 45 sec, it 
was allowed to boil again for another 5 min. Then, the colloi-
dal gold solution was stirred for additional 10 min at room 
temperature (RT) and stored in a dark bottle at 4˚C until used. 
The recombinant antigens of T. gondii (rTgAg) were conjugated 
with 40-nm colloidal gold particles as described previously 
[18]. Briefly, rTgAg dialyzed against PBS and the gold solution 
adjusted to pH 9.0 with 0.2M K2CO3 were mixed at the ratio 
of 1 mg protein to 100 ml gold solution (~2.0 at OD540). The 
mixture was incubated for 30 min at RT and then blocked with 
1% BSA for 30 min. The conjugate was then washed with PBS 
containing 1% BSA and the OD of rTgAg-gold conjugate was 
measured at 450 nm.
Preparation of strip for rapid diagnostic test (RDT)
The composition of RDT device to detect T. gondii-specific 
antibodies (named as “TgRDT” in this report) is shown in Fig. 
1. The test device was prepared as follows: recombinant pro-
tein as capturer was immobilized to an appropriate position 
Fig. 1. Diagram of TgRDT strip to detect antibodies against T. 
gondii. rTgAg was immobilized onto the T region and anti-mouse 
IgG was onto the C area of the strip. Conjugate pad contains 
rTgAg- and mouse IgG-conjugated gold colloid. ① sample pad; 
② blood separation pad; ③ conjugate pad; ④ nitrocellulose 
mem  brane; ⑤ plastic backbone; ⑥ absorbance pad; ⑦ test 
line (T); and ⑧ control line (C).
①
②
③
④
⑤
⑥
⑦
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of the nitrocellulose membrane (control line [C]; 1.0 mg/ml 
of goat anti-mouse IgG, test line [T]; 1.0 mg/ml of rTgAg), and 
then the membrane was dried at RT. The rTgAg- and mouse 
IgG-conjugated gold colloid was treated simultaneously, dried 
on a glass fiber, and used as the conjugate pad. Sample pad 
was prepared from the treatment of cellulose paper with 0.1M 
Tris-Cl (pH 8.0) containing 0.5% polyvinylalcohol (PVA) and 
0.5% Tween-20. For the absorbance pad, the cellulose paper 
was used without any treatment. The test strip was assembled 
in the order shown in Fig. 1. All pads were partially overlapped 
to ensure uninterrupted migration of the sample solution along 
the test strip. The test strip was finally assembled in a plastic 
cassette.
Assay procedure and interpretation of TgRDT
As shown in Fig. 2A, when the test strip is assembled in a 
plastic cassette, there is one hole which connects to the sample 
pad. The assay procedure started by loading 10 μl of blood sam-
ple onto the hole, and then loading 3 drops (approximately 
100 μl) of 0.1M Tris-Cl buffer (pH 8.0) containing 0.1% ca-
sein and 1% Tween-20 to the sample pad. Approximately 5-10 
min after the application of the buffer, the results were inter-
preted. Control line (C) should appear in all tests. If a red col-
or band appears at the T line, it means that the specimen con-
tains anti-T. gondii antibodies (Fig. 2A).
Analytical sensitivity of TgRDT
To investigate the analytical sensitivity of TgRDT, we used 3 
different positive specimens. The sera from cats were serially 
diluted with negatives ranging from 1 to 128 folds and then 
they were used to the testing. The detection threshold level of 
the kit was compared with the commercial ELISA kit, ID Screen® 
Toxoplasmosis Indirect, which has been used popularly in Ko-
rea. The S/P values were calculated by the following formula 
according to the direction of the kit insert.
S/P =                                                                             ×100
If the S/P value is greater than or equal to 50%, the sample 
is considered positive to anti-T. gondii antibodies. Otherwise, 
the sample is considered negative or doubtful.
Clinical assessment of TgRDT
Total 182 cases of feline specimens were used for evaluating 
Optical density of sample (ODsample)
Optical density of positive control (ODpc)
Fig. 2. (A) Positive and negative results of the assembled TgRDT kit. (B) Immuno-reactivities of rSAG1, rSAG2, and rGRA6 to antibod-
ies against T. gondii. ① rSAG1-applied; ② rSAG2-applied; and ③ rGRA6-applied.
A
Positive Negative
B
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the TgRDT developed in this study. All the samples were com-
paratively tested by the commercial ELISA kit. For confirmation 
of the samples, western blot analysis was carried out. Clinical 
accuracy of the TgRDT kit, including sensitivity, specificity, and 
kappa values was calculated by the general diagnostic formu-
las [19]. 
RESULTS
Antigenic properties of the recombinant proteins from T. 
gondii
Among the 4 kinds of rTgAg, namely SAG1, SAG2, GRA3, 
and GRA6, GRA3 was expressed as the inclusion body, hence, 
the protein was excluded from further analysis (data not shown). 
The remaining 3 recombinant proteins were successfully ex-
pressed and purified. Then, the antigens were applied to RDT 
system as described previously. As shown in Fig. 2B, SAG2 and 
GRA6 showed weak reactivity to the anti-T. gondii antibody-
positive serum from cats. To check the overall antigenic reac-
tivities of the proteins with respect to various positive sera, we 
tested with mixture of 10 kinds of positive sera. Among the an-
tigens tried, SAG1 gave very strong antigenic reactivity to the 
positive serum so that we introduced this protein to the TgRDT 
kit in this study.
Analytical sensitivity of TgRDT with SAG1 protein
To compare the detection threshold levels of TgRDT and 
ELISA kit, 3 different sera had been verified to be positive for 
anti-T. gondii antibody by western blot (data not shown). The 
positive sera were serially diluted with the verified negative se-
rum. As shown in Table 1, the detection threshold levels using 
those diluents were 38.2, 24.7, and 68.9 S/P for TgRDT, and 
93.1, 97.9, and 68.9 for ELISA, respectively. These data indi-
cate that the cut-off value of TgRDT (43.9 S/P) is approximate-
ly ~2-folds lower than that of ELISA (86.6 S/P).
Clinical accuracy of rSAG1-loaded RDT
Total 55 household and 127 stray feline sera were tested in 
this clinical study. As shown in Table 2, the TgRDT has showed 
excellent and promising clinical performances. Its sensitivity 
was 100% (23/23) even though the number of positive sam-
ples was limited, and its specificity was 99.2% (158/159). In 
the case of ELISA kit, it showed 91.3% of clinical sensitivity (21/ 
Table 1. Analytical sensitivity of TgRDT and ELISA 
Positive  
sample (ID) Dilution fold S/P value
Detection thresholds
TgRDT ELISA
No. 1 (#33) 4 132 + +
16 125 + +
64 69 +w +
128 42 +w -
256 24 - -
No. 2 (#141) 4 140 ++ +
16 98 + +
64 49 + -
128 25 +w -
256 16 - -
No. 3 (#154) 4 134 + +
16 93 + +
64 38 +w -
128 23 - -
There were no discrepancies between observations made by 2 techni-
cians.
+, positive; +w, very weak positive; and -, negative.
A  B  C  D  E
(kDa)
104.0
81.0
47.7
34.6
28.3
19.2
Fig. 3. Western blot analysis of 5 specimens having different re-
sults between TgRDT and ELISA.
Table 2. Clinical performance of TgRDT and ELISA 
Reference 
results
TgRDT ELISA
Positive  Negative Total Positive Negative Total
Positive 23 0 23 21 2 23
Negative 1 158 159 2 157 159
Total 24 158 182 23 159 182  Chong et al.: Rapid serodiagnosis for toxoplasmosis of cats using rSAG1   211
23) and 98.7% of clinical specificity (157/159). The kappa val-
ue of these 2 methods was 0.88. Five cases of cat sera showed 
different results between TgRDT and ELISA. Fig. 3 is the results 
of western blot analysis for confirmation, of which 2 cases (C 
and E) showed typical band patterns of T. gondii positive se-
rum and the other 3 cases were negative. All the results were 
analyzed following the method of Sohn and Nam [20].
DISCUSSION
There are several recombinant proteins of T. gondii known as 
potential candidates for the diagnostic use to detect its antibo-
dies in cats and also in humans. Among them, SAG1 is one of 
the most suitable proteins for diagnostic system because of its 
structural abundance in T. gondii and better antigenic proper-
ties. In this study, we demonstrated that rSAG1 effectively de-
tected T. gondii antibodies in cats, and that the recombinant 
protein could replace somatic antigens of T. gondii in the diag-
nosis. The rSAG1-loaded TgRDT showed very good analytical 
sensitivity in our experiments (2-fold more sensitive than ELI-
SA kit). Furthermore, the high analytical sensitivity and the use 
of recombinant protein produced excellent results of clinical 
assessment of TgRDT (100% of sensitivity and 99.2% of speci-
ficity).
According to the algorithm of kappa statistics, the kappa val-
ue shall range from 0 to 1, and a kappa value of more than 0.7 
typically indicates strong agreement of 2 methods [19]. In our 
clinical trial, Cohen’s kappa value of TgRDT and a commercial 
ELISA kit was 0.88 indicating that both kits have very good con-
cordance to detect the antibodies against T. gondii. This result 
also suggests that the recombinant SAG1 can be used as a choi-
ce of diagnostic antigen instead of somatic antigens, such as T. 
gondii lysate without compromise.
In the field trial of this study, cat sera collected in Gyeonggi-
do and Jeollabuk-do provinces showed 12.6% of Tg Ab-posi-
tive rates (23/182), but there was a significant difference in the 
Tg Ab-positive rates between household and stray cats. House-
hold cats showed 1.8% of Tg Ab positive rate (1/55) but stray 
cats gave 17.3% of Tg Ab positive rate (22/159), which showed 
compatible positive rates done earlier [21-23] and suggested 
overall prevalence of T. gondii infection in Korean cats. This re-
flects the pet-loving behavior of Korean people as clean as pos-
sible and severely restricting the physical activity of cats within 
house. Therefore, the household cat is well controlled from T. 
gondii infection whereas the stray cats are exposed to more har-
sh environment to be infected with T. gondii and may function 
as transmitter of this parasite to the other cats and intermedi-
ate animals according to the due infection routes.
In conclusion, to our knowledge, this TgRDT is the first rSA-
G1-based RDT kit to diagnose T. gondii-specific antibodies. The 
kit is simple to use, rapid to assay, and very sensitive and high-
ly specific. Therefore, it would serve as a choice of method for 
point-of-care diagnosis of T. gondii infection in cat under clini-
cal or field conditions. Further studies are ongoing to device 
for the diagnostic utility of T. gondii infection in humans and 
for discrimination of IgM and IgG against T. gondii.
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